R&D Europe91224323
08:00 AM BST

Medicinal Chemistry

Strategy Meeting Europe 2022

The premier meeting for European Medicinal Chemistry professionals


What makes our strategy meetings unique?


Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.


Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across Europe, you can network with peers from different locations, all in one place.


Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.


Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.


Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.


Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Become an official strategy meeting partner

Whatever your business needs, we can help. Get in touch for partnering opportunities

Press play to hear what your colleagues had to say...

See the full agenda and facilitator line-up

Download the strategy meeting brochure for full details

Meet Our 2022 Speakers

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our 2022 Medicinal Chemistry strategy meeting.

Matthew Segall

CEO Optibrium

Scott McDonald

Director of Business Development Optibrium

Dave Madge

VP WuXi Discovery Services WuXi AppTec

Andreas Bender

Professor, Molecular Informatics University of Cambridge

Roland Bürli

VP, Chemistry Cerevance

Ian Churcher

Chief Scientific Officer Amphista Therapeutics Limited

Werngard Czechtizky

Head, Medicinal Chemistry, RIA AstraZeneca

Matthew Fyfe

Head of Chemistry and Intellectual Property Sitryx Therapeutics

Abdul Hamid Merii

Machine Learning Engineer Silence Therapeutics

Robert Heald

VP, Chemistry Artios Pharma

György Keseru

Principal Investigator Research Centre for Natural Sciences

Guido Koch

Chief Executive Officer Amphilix AG

Pierre Morieux

Chemistry Product Marketing Manager PerkinElmer

Garry Pairaudeau

Chief Technology Officer Exscientia

Graham Simpson

SVP, Drug Discovery Dunad Therapeutics

Marie Wikstrom Lindholm

SVP, Head of Molecular Design Silence Therapeutics
Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.